Table 1. Subject demographics.
| Cohort | N | Gender | Age In years Mean (range) | Diabetes * | ||
|---|---|---|---|---|---|---|
| Male n (%) | Female n (%) | Pre-diagnosed * n (%) | Study definition * n (%) | |||
| Melioid Cohort all | 200 | 133 (67%) | 67 (33%) | 55 (19–89) | 117 (59%) | 134 (67%) |
| Melioid Cohort with Diabetes | 134 | 84 (63%) | 50 (37%) | 53 (19–89) | 117 (87%) | 134 (100%) |
| Melioid Cohort no Diabetes | 66 | 49 (74%) | 17 (26%) | 58 (25–88) | 0 (0%) | 0 (0%) |
| Diabetes Controls Cohort | 45 | 30 (67%) | 15 (33%) | 57 (23–76) | 45 (100%) | 45 (100%) |
| Heathy Controls Cohort | 43 | 26 (60%) | 17 (40%) | 48 (33–73) | 0 (0%) | 0 (0%) |
The gender, age and diabetes status of subjects in the study are shown. Two thirds (67%) of the patients with acute melioidosis were male, with a mean age of 55 years.
*Diabetes definitions are as follows: Pre-diagnosed = subjects with a previous diagnosis of diabetes mellitus by a doctor. Study definition = subjects with a previous diagnosis of diabetes mellitus by a doctor and / or having an HbA1c of ≥ 7%.